277 related articles for article (PubMed ID: 31071311)
1. Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement.
Polyzos SA; Perakakis N; Mantzoros CS
Metabolism; 2019 Jul; 96():66-82. PubMed ID: 31071311
[TBL] [Abstract][Full Text] [Related]
2. Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy.
Javor ED; Ghany MG; Cochran EK; Oral EA; DePaoli AM; Premkumar A; Kleiner DE; Gorden P
Hepatology; 2005 Apr; 41(4):753-60. PubMed ID: 15791619
[TBL] [Abstract][Full Text] [Related]
3. The liver diseases of lipodystrophy: the long-term effect of leptin treatment.
Safar Zadeh E; Lungu AO; Cochran EK; Brown RJ; Ghany MG; Heller T; Kleiner DE; Gorden P
J Hepatol; 2013 Jul; 59(1):131-7. PubMed ID: 23439261
[TBL] [Abstract][Full Text] [Related]
4. Leptin in the treatment of lipodystrophy-associated nonalcoholic fatty liver disease: are we there already?
Machado MV; Cortez-Pinto H
Expert Rev Gastroenterol Hepatol; 2013 Aug; 7(6):513-5. PubMed ID: 23985000
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in understanding lipodystrophy: a focus on lipodystrophy-associated cardiovascular disease and potential effects of leptin therapy on cardiovascular function.
Bruder-Nascimento T; Kress TC; Belin de Chantemele EJ
F1000Res; 2019; 8():. PubMed ID: 31656583
[TBL] [Abstract][Full Text] [Related]
6. Metreleptin treatment of non-HIV lipodystrophy syndromes.
Chevalier B; Lemaitre M; Leguier L; Mapihan KL; Douillard C; Jannin A; Espiard S; Vantyghem MC
Presse Med; 2021 Nov; 50(3):104070. PubMed ID: 34571177
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy.
Ebihara K; Kusakabe T; Hirata M; Masuzaki H; Miyanaga F; Kobayashi N; Tanaka T; Chusho H; Miyazawa T; Hayashi T; Hosoda K; Ogawa Y; DePaoli AM; Fukushima M; Nakao K
J Clin Endocrinol Metab; 2007 Feb; 92(2):532-41. PubMed ID: 17118991
[TBL] [Abstract][Full Text] [Related]
8. Acquired partial lipodystrophy is associated with increased risk for developing metabolic abnormalities.
Akinci B; Koseoglu FD; Onay H; Yavuz S; Altay C; Simsir IY; Ozisik S; Demir L; Korkut M; Yilmaz N; Ozen S; Akinci G; Atik T; Calan M; Secil M; Comlekci A; Demir T
Metabolism; 2015 Sep; 64(9):1086-95. PubMed ID: 26139569
[TBL] [Abstract][Full Text] [Related]
9. Adipokines in the HIV/HAART-associated lipodystrophy syndrome.
Paruthi J; Gill N; Mantzoros CS
Metabolism; 2013 Sep; 62(9):1199-205. PubMed ID: 23706880
[TBL] [Abstract][Full Text] [Related]
10. Leptin replacement therapy in the management of lipodystrophy syndromes.
Vigouroux C; Mosbah H; Vatier C
Ann Endocrinol (Paris); 2024 Jun; 85(3):201-204. PubMed ID: 38871500
[TBL] [Abstract][Full Text] [Related]
11. [Therapy resistant diabetes mellitus and lipodystrophy: leptin therapy leads to improvement].
Jazet IM; Jonker JT; Wijngaarden MA; Lamb H; Smelt AH
Ned Tijdschr Geneeskd; 2013; 157(4):A5482. PubMed ID: 23343738
[TBL] [Abstract][Full Text] [Related]
12. Monogenic forms of lipodystrophic syndromes: diagnosis, detection, and practical management considerations from clinical cases.
Vatier C; Vantyghem MC; Storey C; Jéru I; Christin-Maitre S; Fève B; Lascols O; Beltrand J; Carel JC; Vigouroux C; Bismuth E
Curr Med Res Opin; 2019 Mar; 35(3):543-552. PubMed ID: 30296183
[TBL] [Abstract][Full Text] [Related]
13. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.
Petersen KF; Oral EA; Dufour S; Befroy D; Ariyan C; Yu C; Cline GW; DePaoli AM; Taylor SI; Gorden P; Shulman GI
J Clin Invest; 2002 May; 109(10):1345-50. PubMed ID: 12021250
[TBL] [Abstract][Full Text] [Related]
14. Serum adiponectin and leptin levels in patients with lipodystrophies.
Haque WA; Shimomura I; Matsuzawa Y; Garg A
J Clin Endocrinol Metab; 2002 May; 87(5):2395. PubMed ID: 11994394
[TBL] [Abstract][Full Text] [Related]
15. Rationale for leptin-replacement therapy for severe lipodystrophy.
Oral EA; Chan JL
Endocr Pract; 2010; 16(2):324-33. PubMed ID: 20061299
[TBL] [Abstract][Full Text] [Related]
16. Lipodystrophies.
Garg A
Am J Med; 2000 Feb; 108(2):143-52. PubMed ID: 11126308
[TBL] [Abstract][Full Text] [Related]
17. Post-liver transplant leptin results in resolution of severe recurrence of lipodystrophy-associated nonalcoholic steatohepatitis.
Casey SP; Lokan J; Testro A; Farquharson S; Connelly A; Proietto J; Angus PW
Am J Transplant; 2013 Nov; 13(11):3031-4. PubMed ID: 24007548
[TBL] [Abstract][Full Text] [Related]
18. Metreleptin Treatment in Patients with Non-HIV Associated Lipodystrophy.
Akinci G; Akinci B
Recent Pat Endocr Metab Immune Drug Discov; 2015; 9(2):74-8. PubMed ID: 26556498
[TBL] [Abstract][Full Text] [Related]
19. Higher adiponectin levels in patients with Berardinelli-Seip congenital lipodystrophy due to seipin as compared with 1-acylglycerol-3-phosphate-o-acyltransferase-2 deficiency.
Antuna-Puente B; Boutet E; Vigouroux C; Lascols O; Slama L; Caron-Debarle M; Khallouf E; Lévy-Marchal C; Capeau J; Bastard JP; Magré J
J Clin Endocrinol Metab; 2010 Mar; 95(3):1463-8. PubMed ID: 20097706
[TBL] [Abstract][Full Text] [Related]
20. Lipodystrophies-Disorders of the Fatty Tissue.
Knebel B; Müller-Wieland D; Kotzka J
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
